223 related articles for article (PubMed ID: 28489780)
1. Prognostic and clinicopathological significance of cyclin B expression in patients with breast cancer: A meta-analysis.
Sun X; Zhangyuan G; Shi L; Wang Y; Sun B; Ding Q
Medicine (Baltimore); 2017 May; 96(19):e6860. PubMed ID: 28489780
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological and prognostic significance of cyclin D1 amplification in patients with breast cancer: a meta-analysis.
He Q; Wu J; Liu XL; Ma YH; Wu XT; Wang WY; An HX
J BUON; 2017; 22(5):1209-1216. PubMed ID: 29135104
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of cyclin D1 expression in colorectal cancer: a meta-analysis of observational studies.
Li Y; Wei J; Xu C; Zhao Z; You T
PLoS One; 2014; 9(4):e94508. PubMed ID: 24728073
[TBL] [Abstract][Full Text] [Related]
4. Loss of PTEN expression in breast cancer: association with clinicopathological characteristics and prognosis.
Li S; Shen Y; Wang M; Yang J; Lv M; Li P; Chen Z; Yang J
Oncotarget; 2017 May; 8(19):32043-32054. PubMed ID: 28410191
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Significance of Cyclin D1 Expression in Renal Cell Carcinoma: a Systematic Review and Meta-analysis.
Li Z; Liu J; Zhang X; Fang L; Zhang C; Zhang Z; Yan L; Tang Y; Fan Y
Pathol Oncol Res; 2020 Jul; 26(3):1401-1409. PubMed ID: 31748879
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of MMP Family Members Functions as Prognostic Biomarker for Breast Cancer Patients: A Systematic Review and Meta-Analysis.
Ren F; Tang R; Zhang X; Madushi WM; Luo D; Dang Y; Li Z; Wei K; Chen G
PLoS One; 2015; 10(8):e0135544. PubMed ID: 26270045
[TBL] [Abstract][Full Text] [Related]
7. Prognostic and clinicopathological significance of Cks1 in cancer: Evidence from a meta-analysis.
Zhang Y; Chen Y; You F; Li W; Lang Z; Zou Z
J Cell Physiol; 2019 Aug; 234(8):13423-13430. PubMed ID: 30605238
[TBL] [Abstract][Full Text] [Related]
8. Prognostic and clinicopathological value of PD-L1 expression in primary breast cancer: a meta-analysis.
Huang W; Ran R; Shao B; Li H
Breast Cancer Res Treat; 2019 Nov; 178(1):17-33. PubMed ID: 31359214
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological and Prognostic Significance of CBX3 Expression in Human Cancer: a Systematic Review and Meta-analysis.
Lin H; Zhao X; Xia L; Lian J; You J
Dis Markers; 2020; 2020():2412741. PubMed ID: 33273987
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological and prognostic role of SIRT1 in breast cancer patients: a meta-analysis.
Cao YW; Li YC; Wan GX; Du XM; Li F
Int J Clin Exp Med; 2015; 8(1):616-24. PubMed ID: 25785036
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of long non-coding RNA FOXD2-AS1 expression in patients with solid tumors.
Zhou L; Li Z; Shao X; Yang B; Feng J; Xu L; Teng Y
Pathol Res Pract; 2019 Sep; 215(9):152449. PubMed ID: 31378453
[TBL] [Abstract][Full Text] [Related]
12. Prognostic and clinicopathological value of Twist expression in breast cancer: A meta-analysis.
Qiao W; Jia Z; Liu H; Liu Q; Zhang T; Guo W; Li P; Deng M; Li S
PLoS One; 2017; 12(10):e0186191. PubMed ID: 29016671
[TBL] [Abstract][Full Text] [Related]
13. Prognostic and clinicopathological value of GATA binding protein 3 in breast cancer: A systematic review and meta-analysis.
Guo Y; Yu P; Liu Z; Maimaiti Y; Chen C; Zhang Y; Yin X; Wang S; Liu C; Huang T
PLoS One; 2017; 12(4):e0174843. PubMed ID: 28394898
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of cyclin B1 and cyclin B2 expression in breast cancer: A systematic review and updated meta-analysis.
Kang J; Jung H; Kim H
Medicine (Baltimore); 2024 Jan; 103(3):e37016. PubMed ID: 38241547
[TBL] [Abstract][Full Text] [Related]
15. The prognostic value of cyclin D1 expression in the survival of cancer patients: A meta-analysis.
Moradi Binabaj M; Bahrami A; Khazaei M; Ryzhikov M; Ferns GA; Avan A; Mahdi Hassanian S
Gene; 2020 Feb; 728():144283. PubMed ID: 31838249
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of different cut-off levels of Ki-67 in breast cancer: a systematic review and meta-analysis of 64,196 patients.
Petrelli F; Viale G; Cabiddu M; Barni S
Breast Cancer Res Treat; 2015 Oct; 153(3):477-91. PubMed ID: 26341751
[TBL] [Abstract][Full Text] [Related]
17. The clinicopathologic impacts and prognostic significance of GLUT1 expression in patients with lung cancer: A meta-analysis.
Zhang B; Xie Z; Li B
Gene; 2019 Mar; 689():76-83. PubMed ID: 30552981
[TBL] [Abstract][Full Text] [Related]
18. Cyclin E1 is a strong prognostic marker for death from lymph node negative breast cancer. A population-based case-control study.
Lundgren C; Ahlin C; Holmberg L; Amini RM; Fjällskog ML; Blomqvist C
Acta Oncol; 2015 Apr; 54(4):538-44. PubMed ID: 25327158
[TBL] [Abstract][Full Text] [Related]
19. Prognostic and clinicopathological significance of SR-B1 in solid tumors: A meta-analysis.
Wang M; Chao C; Luo G; Wang B; Zhan X; Di D; Qian Y; Zhang X
Pathol Res Pract; 2020 Apr; 216(4):152849. PubMed ID: 32057516
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological and prognostic significance of nestin expression in patients with breast cancer: a systematic review and meta-analysis.
Zhang X; Xing C; Guan W; Chen L; Guo K; Yu A; Xie K
Cancer Cell Int; 2020; 20():169. PubMed ID: 32467665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
